Literature DB >> 8599584

Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.

S G Khan1, R R Mohan, S K Katiyar, G S Wood, D R Bickers, H Mukhtar, R Agarwal.   

Abstract

The activation of ras proto-oncogenes by point mutation in a broad spectrum of clinical malignancies and experimentally induced tumors suggests their critical role in cancer induction. To determine whether the activation of ras proto-oncogenes by point mutation also contributes to ultraviolet B radiation (UVB)-induced skin tumorigenesis and whether this event is responsible for the different tumorigenic potentials of UVB radiation in different mouse strains, we analyzed the skin tumors induced by UVB in SKH-1 hairless and C3H mice for specific mutations in the Ha-, Ki-, and N-ras oncogenes. With the same UVB irradiation protocol, the latency period for tumor appearance was longer in C3H mice than in SKH-1 hairless mice. In addition, tumor incidence and multiplicity were also significantly higher (P<0.001, chi square and Wilcoxon rank sum tests) in SKH-1 hairless mice compared with C3H mice. None of the 30 skin tumor specimens (15 from each mouse strain) analyzed by polymerase chain reaction (PCR) amplification of specific codons followed by dot-blot hybridization with specific probes contained mutation in codons 13 of Ha-ras; 12, 13, and 61 of Ki-ras; or 12 and 13 of N-ras. However, three of the 15 tumors in SKH-1 hairless mice showed either a G35-->A or G35-->T transition at second position of Ha-ras codon 12. Interestingly, one of these tumors (with a G35-->A transition) also harbored an A182-->G mutation at second position of Ha-ras codon 61. None of the tumors from C3H mice showed mutations in codons 12 or 61 of the Ha-ras oncogene. With regard to codon 61 of the N-ras oncogene, six tumors from SKH-1 hairless mice and 10 tumors from C3H mice showed an A183-->T transversion. While G35-->A or G35-->T transition detected by PCR and dot-blot hybridization was confirmed by sequencing, the mutations identified similarly at codon 61 in either the Ha- or N-ras oncogenes could not be verified by sequencing of PCR-amplified products subcloned into plasmid vectors. With the exception of the low incidence of Ha-ras oncogene mutations at codon 12 in SKH-1 hairless mouse skin tumors induced by UVB, the striking absence of mutations in the Ha-, Ki-, and N-ras oncogenes in UVB-induced mouse skin tumors suggests that ras oncogene mutations are rare and thus are not an initiating event in photocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599584     DOI: 10.1002/(SICI)1098-2744(199602)15:2<96::AID-MC2>3.0.CO;2-P

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  4 in total

1.  TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.

Authors:  Hiroyuki Yamamoto; Joohyun Ryu; Eli Min; Naomi Oi; Ruihua Bai; Tatyana A Zykova; Dong Hoon Yu; Kenji Moriyama; Ann M Bode; Zigang Dong
Journal:  J Invest Dermatol       Date:  2017-01-25       Impact factor: 8.551

2.  Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase.

Authors:  Masaoki Kawasumi; Bianca Lemos; James E Bradner; Renee Thibodeau; Yong-son Kim; Miranda Schmidt; Erin Higgins; Sang-wahn Koo; Aimee Angle-Zahn; Adam Chen; Douglas Levine; Lynh Nguyen; Timothy P Heffernan; Isabel Longo; Anna Mandinova; Yao-Ping Lu; Allan H Conney; Paul Nghiem
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

3.  Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas.

Authors:  Giuseppina Della Vittoria Scarpati; Francesco Perri; Salvatore Pisconti; Giuseppe Costa; Filippo Ricciardiello; Salvatore Del Prete; Alberto Napolitano; Marco Carraturo; Salvatore Mazzone; Raffaele Addeo
Journal:  Mol Clin Oncol       Date:  2016-01-27

4.  Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates.

Authors:  Vida Chitsazzadeh; Cristian Coarfa; Jennifer A Drummond; Tri Nguyen; Aaron Joseph; Suneel Chilukuri; Elizabeth Charpiot; Charles H Adelmann; Grace Ching; Tran N Nguyen; Courtney Nicholas; Valencia D Thomas; Michael Migden; Deborah MacFarlane; Erika Thompson; Jianjun Shen; Yoko Takata; Kayla McNiece; Maxim A Polansky; Hussein A Abbas; Kimal Rajapakshe; Adam Gower; Avrum Spira; Kyle R Covington; Weimin Xiao; Preethi Gunaratne; Curtis Pickering; Mitchell Frederick; Jeffrey N Myers; Li Shen; Hui Yao; Xiaoping Su; Ronald P Rapini; David A Wheeler; Ernest T Hawk; Elsa R Flores; Kenneth Y Tsai
Journal:  Nat Commun       Date:  2016-08-30       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.